Approval · Notice of Compliance 20581 · 2018
IXIARO: Notice of Compliance 20581
Issued March 2, 2018
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 20581
- Date
- March 2, 2018
- Company
- Valneva Austria GmbhVienna, Wien, Austria
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Addition of pediatric indication, a rapid immunization schedule for adults and a recommendation for booster dose in adults
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| IXIARO | Not yet assigned | — |
Medicinal ingredients
- JAPANESE ENCEPHALITIS VIRUS VACCINE INACTIVATED 6 UNIT per 0.5ML